Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
January 21, 2008
- Korosho to Expand System to Determine Market Trend for Generics
January 21, 2008
- Reimbursement Prices for 5 Chemotherapy Regimens under DPC System to Be Reconsidered
January 21, 2008
- Nichi-Iko Improves Distribution, Production Systems to Ensure Overnight Deliveries
January 21, 2008
- Int'l Cooperation Needed to Eliminate Counterfeit Drugs: Prof. Kimura
January 21, 2008
- Generics Market Estimated to Reach \338 Billion in 2009: Fuji Keizai
January 21, 2008
- Salagen Improves QOL of Patients with Sjogren's Syndrome
January 21, 2008
- GENERICS NEWS IN BRIEF
January 21, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 21, 2008
- FPMAJ's Pricing System Proposal Not Impossible to Introduce: EAD Director Mr Takeda
January 21, 2008
- Industry Must Quit Yakkasa-Dependent Sales Once for All
January 21, 2008
- Re-pricing Inevitable under Public Health Insurance System: Mr Isobe
January 21, 2008
- Ensure Sustained Growth by Developing Innovative New Drugs: Top Company Leaders
January 21, 2008
- Hire More Ex-Company Employees: Dr Aoki
January 21, 2008
- Takeda, Daiichi Sankyo Files NDAs for Their Future Blockbusters in the US
January 21, 2008
- REGULATORY NEWS IN BRIEF
January 21, 2008
- Meiji Seika Aims at \10 Bil. Sales with Generics
January 21, 2008
- NEW PRODUCTS／Dinagest Tablet for Endometriosis: Mochida
January 21, 2008
- Taisho Licenses TS-032 to Pfizer
January 21, 2008
- Tacere to Codevelop RNAi Hepatitis C Drug with Pfizer
January 21, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…